Stanford University


Showing 1,481-1,490 of 1,582 Results

  • Adam Wang

    Adam Wang

    Assistant Professor of Radiology and, by courtesy, of Electrical Engineering

    BioMy research group develops technologies for advanced x-ray and CT imaging, including artificial intelligence for CT acquisition, reconstruction, and image processing; spectral imaging, including photon counting CT (PCCT) and dual-layer flat-panel detectors; novel system and detector designs; and their applications in diagnostic imaging and image-guided procedures. I am also the Director of the Photon Counting CT Lab, Zeego Lab, and Tabletop X-Ray Lab.

    I completed my PhD in Electrical Engineering at Stanford, developing strategies for maximizing the information content of dual energy CT and photon counting detectors. I then pursued a postdoctoral fellowship at Johns Hopkins in the I-STAR Lab, developing reconstruction and registration methods for x-ray based image-guided surgery. I was then a Senior Scientist at Varian Medical Systems, developing x-ray/CT methods for image-guided radiation therapy, before returning to Stanford in 2018, where I now lead a comprehensive research program in advanced x-ray and CT imaging systems and methods, with funding from NIH, DOD, DOE, and industry partners.

  • Bo Wang

    Bo Wang

    Assistant Professor of Bioengineering and, by courtesy, Developmental Biology

    Current Research and Scholarly InterestsResearch interests:
    (1) Systems biology of whole-body regeneration
    (2) Cell type evolution through the lens of single-cell multiomic sequencing analysis
    (3) Quantitative biology of brain regeneration
    (4) Regeneration of animal-algal photosymbiotic systems

  • C. Jason Wang, MD, PhD

    C. Jason Wang, MD, PhD

    LCY: Tan Lan Lee Professor and Professor of Pediatrics (General Pediatrics) and of Health Policy

    BioDr. Wang is the Director of Center for Policy, Outcomes and Prevention. Prior to coming to Stanford in 2011, he was a faculty member at Boston University Schools of Medicine and Public Health. His other professional experiences include working as a management consultant with McKinsey and Company and serving as the project manager for Taiwan's National Health Insurance Reform Task-force. His current interests include: 1) COVID-19 related policies; 2) developing tools for assessing and improving the value of healthcare; 3) facilitating the use of mobile technology in improving quality of care; 4) supporting competency-based medical education curriculum, and 5) engaging in healthcare delivery and payment reforms.

  • Ge Wang

    Ge Wang

    Associate Professor of Music, Senior Fellow at the Stanford Institute for HAI and Associate Professor, by courtesy, of Computer Science

    BioGe Wang is an Associate Professor at Stanford University in the Center for Computer Research in Music and Acoustics (CCRMA). He specializes in the art of design and computer music — researching programming languages and interactive software design for music, interaction design, mobile music, laptop orchestras, expressive design of virtual reality, aesthetics of music technology design, and education at the intersection of computer science and music. Ge is the author of the ChucK music programming language, the founding director of the Stanford Laptop Orchestra (SLOrk). Ge is also the Co-founder of Smule (reaching over 200 million users), and the designer of the iPhone's Ocarina and Magic Piano. Ge is a 2016 Guggenheim Fellow, and the author of ARTFUL DESIGN: TECHNOLOGY IN SEARCH OF THE SUBLIME—a book on design and technology, art and life‚ published by Stanford University Press in 2018 (see https://artful.design/)

  • Paul  J. Wang, MD

    Paul J. Wang, MD

    John R. and Ai Giak L. Singleton Director, Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Bioengineering

    Current Research and Scholarly InterestsDr. Wang's research centers on the development of innovative approaches to the treatment of arrhythmias, including more effective catheter ablation techniques, more reliable implantable devices, and less invasive treatments. Dr. Wang's clinical research interests include atrial fibrillation, ventricular tachycardia, syncope, and hypertrophic cardiomyopathy. Dr. Wang is committed to addressing disparities in care and is actively involved in increasing diversity in clinical trials.

  • Shan X. Wang

    Shan X. Wang

    Leland T. Edwards Professor in the School of Engineering and Professor of Electrical Engineering and, by courtesy, of Radiology (Molecular Imaging Program at Stanford)

    Current Research and Scholarly InterestsShan Wang was named the Leland T. Edwards Professor in the School of Engineering in 2018. He directs the Center for Magnetic Nanotechnology and is a leading expert in biosensors, information storage and spintronics. His research and inventions span across a variety of areas including magnetic biochips, in vitro diagnostics, cancer biomarkers, magnetic nanoparticles, magnetic sensors, magnetoresistive random access memory, and magnetic integrated inductors.

  • Sui Wang, PhD

    Sui Wang, PhD

    Assistant Professor of Ophthalmology

    Current Research and Scholarly InterestsOur research focuses on unraveling the molecular mechanisms underlying retinal development and diseases. We employ genetic and genomic tools to explore how various retinal cell types, including neurons, glia, and the vasculature, respond to developmental cues and disease insults at the epigenomic and transcriptional levels. In addition, we investigate their interactions and collective contributions to maintain retinal integrity.

    1. Investigating retinal development:
    We utilize genetic tools and methods such as in vivo plasmid electroporation and CRISPR to dissect the roles of cis-regulatory elements and transcription factors in controlling retinal development.

    2. Understanding diabetes-induced cell-type-specific responses in the retina:
    Diabetes triggers a range of multicellular responses in the retina, such as vascular lesions, glial dysfunction, and neurodegeneration, all of which contribute to retinopathy. We delve into the detailed molecular mechanisms underlying these diabetes-induced cell-type-specific responses and the pathogenesis of diabetic retinopathy.

    3. Developing molecular tools for labeling and manipulation of specific cell types in vivo:
    Cis-regulatory elements, particularly enhancers, play pivotal roles in directing tissue- and cell-type-specific expression. Our interest lies in identifying enhancers that can drive cell type-specific expression in the retina and brain. We incorporate these enhancers into plasmid or AAV-based delivery systems, enabling precise labeling and manipulation of specific cell types in vivo.